INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

JOHNSON & JOHNSON

Pharmaceutical Preparations | SIC: 2834
Phone: 732-524-2455

CIK: 0000200406
EIN: 221024240
State Location: NJ
State of Inc.: NJ

NYSE:JNJ

Form: 144

Filing Date: 11 Jun 2026
Report Date:
Accepted: 11 Jun 2026 11:44 a.m.
Accession Number: 0001959173-26-004553

Act: 33
File Number: 001-03215
Film Number: 261082458

Documents

Primary Document

Accepted: 11 Jun 2026 11:44 a.m.

0001959173-26-004553-index-headers.html

Last Modified: 11 Jun 2026 11:44 a.m.

0001959173-26-004553-index.html

Last Modified: 11 Jun 2026 11:44 a.m.

0001959173-26-004553.txt

Last Modified: 11 Jun 2026 11:44 a.m.

primary_doc.xml

Last Modified: 11 Jun 2026 11:44 a.m.